Publications
427
Citations
8,872
Est. group size
—
Recurring co-author estimate
Active years
59
Publishing since 1967
This researcher works in clinical endocrinology, focusing on disorders of the pituitary and adrenal glands, growth hormone conditions, and related metabolic and hormonal health issues. Recent work includes studies on pituitary tumors, adrenal insufficiency treatment and costs, testosterone therapy safety, and metabolic complications in cancer survivors. The research combines clinical trials, patient registry data, and health economics analyses to inform guidelines and treatment practices.
Publication output has gradually declined over the past decade, from around 19-21 papers per year (2017-2019) to roughly 8-10 per year in recent years (2024-2025).
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Metabolic syndrome in childhood, adolescent, and young adult cancer survivors: recommendations for surveillance from the International Late Effects of Childhood Cancer Guideline Harmonization Group
European Journal of Endocrinology · 2025
- Cardiovascular safety of testosterone therapy—Insights from the TRAVERSE trial and beyond: A position statement of the European Expert Panel for Testosterone Research
Andrology · 2025
- APPROACH: Analysis of Proton versus Photon Radiotherapy in Oligodendroglioma and Assessment of Cognitive Health – study protocol paper for a phase III multicentre, open-label randomised controlled trial
BMJ Open · 2025
- Conservatively managed non-functioning pituitary macroadenomas—cohort study from the UK Non-functioning Pituitary Adenoma Consortium
European Journal of Endocrinology · 2025
- Diabetes Risk After Treatment for Childhood and Young Adult Cancer
Diabetes Care · 2025
- Mineralocorticoid effects of fludrocortisone and hydrocortisone in primary adrenal insufficiency: EU-AIR patient data
Journal of Endocrinological Investigation · 2025
- The Cost of Adrenal Insufficiency in England—Analysis of NHS HES Data
Clinical Endocrinology · 2025
- OR25-06 Pituitary gigantism: how much different from acromegaly? A comparison of clinical features and mortality in 3244 Patients
Journal of the Endocrine Society · 2025
- Protecting optimal childhood growth: systematic nutritional screening, assessment, and intervention for children at risk of malnutrition in the Kingdom of Saudi Arabia
Frontiers in Nutrition · 2024
- Are Oral Somatostatin Receptor Ligands Moving Closer to Becoming a Reality?
Clinical Endocrinology · 2024
- The cost burden of hospitalisation for adrenal insufficiency patients in the NHS in england
Endocrine Abstracts · 2024
- A young Acromegalic patient (AIP+) with poor response to SRLs and discordant GH / IGF1
Endocrine Abstracts · 2024
- Gestational diabetes insidious
Endocrine Abstracts · 2024
- Comprehensive overview of acromegaly management
Endocrine Abstracts · 2024
- Audit on the Management of Cystic Prolactinomas
Endocrine Abstracts · 2024
- Endocrine Abstracts×38
- Clinical Endocrinology×12
- The Journal of Clinical Endocrinology & Metabolism×7
- Journal of the Endocrine Society×7
- European Journal of Endocrinology×5
- Luma Ghalib
Medicine · The Ohio State University
- Diane Donegan
Medicine · Indiana University
- Rohan K. Henry
Medicine · The Ohio State University
- Dante Pezzutti
Medicine · The Ohio State University
- Michelle Wedemeyer
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile